These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Antidepressant-like effect of delta9-tetrahydrocannabinol and other cannabinoids isolated from Cannabis sativa L. El-Alfy AT; Ivey K; Robinson K; Ahmed S; Radwan M; Slade D; Khan I; ElSohly M; Ross S Pharmacol Biochem Behav; 2010 Jun; 95(4):434-42. PubMed ID: 20332000 [TBL] [Abstract][Full Text] [Related]
25. Concentrations of delta9-tetrahydrocannabinol and 11-nor-9-carboxytetrahydrocannabinol in blood and urine after passive exposure to Cannabis smoke in a coffee shop. Röhrich J; Schimmel I; Zörntlein S; Becker J; Drobnik S; Kaufmann T; Kuntz V; Urban R J Anal Toxicol; 2010 May; 34(4):196-203. PubMed ID: 20465865 [TBL] [Abstract][Full Text] [Related]
26. Potency trends of cannabis in Jamaica during the period of 2014 to 2020. Lindsay CM; Bernard KK; Hammond AM; Beckford S; Abel WD; Brown PD; Young LE Drug Test Anal; 2024 Feb; 16(2):174-186. PubMed ID: 37309060 [TBL] [Abstract][Full Text] [Related]
27. Delta 9-tetrahydrocannabinol discrimination in rats as a model for cannabis intoxication. Balster RL; Prescott WR Neurosci Biobehav Rev; 1992; 16(1):55-62. PubMed ID: 1313164 [TBL] [Abstract][Full Text] [Related]
28. A crowdsourcing survey study on the subjective effects of delta-8-tetrahydrocannabinol relative to delta-9-tetrahydrocannabinol and cannabidiol. Bergeria CL; Strickland JC; Spindle TR; Kalaba M; Satyavolu PU; Feldner M; Vandrey R; Bonn-Miller M; Peters EN; Weerts E Exp Clin Psychopharmacol; 2023 Apr; 31(2):312-317. PubMed ID: 35467921 [TBL] [Abstract][Full Text] [Related]
29. The cross-reactivity of cannabinoid analogs (delta-8-THC, delta-10-THC and CBD), their metabolites and chiral carboxy HHC metabolites in urine of six commercially available homogeneous immunoassays. Wolf CE; Pokhai AA; Poklis JL; Williams GR J Anal Toxicol; 2023 Nov; 47(8):732-736. PubMed ID: 37602947 [TBL] [Abstract][Full Text] [Related]
30. Emergence of the less common cannabinoid Δ Rzeppa S; Große J; Rautenberg C; Thieme D; Lepp T; Vallimäe H; Keiler AM Drug Test Anal; 2021 Nov; 13(11-12):1936-1943. PubMed ID: 34494719 [TBL] [Abstract][Full Text] [Related]
31. Psychomotor performance in relation to acute oral administration of Delta9-tetrahydrocannabinol and standardized cannabis extract in healthy human subjects. Roser P; Gallinat J; Weinberg G; Juckel G; Gorynia I; Stadelmann AM Eur Arch Psychiatry Clin Neurosci; 2009 Aug; 259(5):284-92. PubMed ID: 19224107 [TBL] [Abstract][Full Text] [Related]
32. Altered Corticolimbic Control of the Nucleus Accumbens by Long-term Δ Hwang EK; Lupica CR Biol Psychiatry; 2020 Apr; 87(7):619-631. PubMed ID: 31543247 [TBL] [Abstract][Full Text] [Related]
33. Proof of active cannabis use comparing 11-hydroxy-∆9-tetrahydrocannabinol with 11-nor-9-carboxy-tetrahydrocannabinol concentrations. Franz T; Skopp G; Schwarz G; Musshoff F Drug Test Anal; 2018 Oct; 10(10):1573-1578. PubMed ID: 29845743 [TBL] [Abstract][Full Text] [Related]
34. Metabolomics of Δ9-tetrahydrocannabinol: implications in toxicity. Dinis-Oliveira RJ Drug Metab Rev; 2016; 48(1):80-7. PubMed ID: 26828228 [TBL] [Abstract][Full Text] [Related]
35. Abstinence phenomena of chronic cannabis-addicts prospectively monitored during controlled inpatient detoxification (Part II): Psychiatric complaints and their relation to delta-9-tetrahydrocannabinol and its metabolites in serum. Bonnet U; Borda T; Scherbaum N; Specka M Drug Alcohol Depend; 2015 Oct; 155():302-6. PubMed ID: 26298553 [TBL] [Abstract][Full Text] [Related]
36. A Comprehensive Review of Cannabis Potency in the United States in the Last Decade. ElSohly MA; Chandra S; Radwan M; Majumdar CG; Church JC Biol Psychiatry Cogn Neurosci Neuroimaging; 2021 Jun; 6(6):603-606. PubMed ID: 33508497 [TBL] [Abstract][Full Text] [Related]
37. Oral fluid cannabinoids in chronic, daily Cannabis smokers during sustained, monitored abstinence. Lee D; Milman G; Barnes AJ; Goodwin RS; Hirvonen J; Huestis MA Clin Chem; 2011 Aug; 57(8):1127-36. PubMed ID: 21677094 [TBL] [Abstract][Full Text] [Related]
38. Potency testing of up to twenty cannabinoids by liquid chromatography diode array detector with optional electrospray ionization time-of-flight mass spectrometry. Song L; Valenzuela G; Carlson S; Dodson Z; Adisa M Anal Chim Acta; 2022 May; 1207():339827. PubMed ID: 35491034 [TBL] [Abstract][Full Text] [Related]
39. Dronabinol Prescribing and Exposure Among Children and Young Adults Diagnosed with Cancer. Rower JE; King AD; Wilkins D; Wilkes J; Yellepeddi V; Maese L; Lemons RS; Constance JE J Adolesc Young Adult Oncol; 2021 Apr; 10(2):175-184. PubMed ID: 32678694 [No Abstract] [Full Text] [Related]
40. [Determination of 11 Cannabinoids in Cannabis sativa L. by Liquid Chromatography Quadrupole Time-of-Flight Mass Spectrometry (LC-Q-TOF-MS)]. Tanaka R; Mizutani S; Kawamura M; Fuchino H; Kawahara N; Kikura-Hanajiri R Yakugaku Zasshi; 2023; 143(4):411-418. PubMed ID: 37005243 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]